XML 12 R1.htm IDEA: XBRL DOCUMENT v3.8.0.1
Document And Entity Information - shares
 9 Months Ended
Sep. 30, 2017
Nov. 01, 2017
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2017  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q3  
Entity Registrant Name Protalix BioTherapeutics, Inc.  
Entity Central Index Key 0001006281  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Trading Symbol PLX  
Entity Common Stock, Shares Outstanding   139,727,673